A Nonrandomized Trial of the Effects of Passive Simulated Jogging on Short-Term Heart Rate Variability in Type 2 Diabetic Subjects

Table 1

Study participants’ characteristics.

Subject	Gender	Age range (yrs)	BMI	Blood pressure () (mmHg)	Medications
1	F	73-75	27.8^ow	146/82	Atorvastatin, losartan, Synthroid, Jentadueto, clonazepam, Brilinta, famotidine, Wellbutrin, and pantoprazole
2	F	64-66	44.8^ob	134/81	Tradjenta, metformin
3	F	58-63	29.3^ow	143/83	Lisinopril, B complex, metformin, and insulin
4	F	51-56	28.8^ow	161/96	Metformin, insulin
5	F	76-80	29.0^ow	152/76	Synthroid, Vitoza
6	M	66-70	24^nl	140/80	Insulin, potassium, atorvastatin, metoprolol, lisinopril, amlodipine, pantoprazole, clopidogrel, and bumetanide
7	M	62-65	29.7^ow	130/71	Metformin
8	M	44-49	24^nl	135/75	Insulin, levothyroxine, vitamin B12, Truvada, and magnesium
9	F	44-49	26.2^nl	126/80	Glipizide, gemfibrozil, metformin, and aspirin
10	F	51-56	29.7^ow	142/83	Metformin

This table represents the study participants characteristics: study subject number (No), gender, age range (years), calculated body mass index (BMI) (nl: normal weight; ow: overweight; ob: obese), baseline blood pressure (systolic/diastolic), and current medications. Mean and standard deviation (SD) for each column. Age range is used to protect any participant identifiable information.